Balanced news tone
News Sentiment
CERS sentiment intelligence
Cerus Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-1.3% over one week, +21.9% over four weeks, trend active, and materially above fair value.
Cerus Corporation to release Q2 2026 results on July 30
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
5 Best Genomics Stocks to Buy According to Analysts
This article identifies Cerus Corporation (NASDAQ: CERS) as a top genomics stock to buy, with analysts projecting a 66.05% upside potential. Cerus recently secured a new debt facility of up to $110 million, which is expected to cut annual cash interest expenses by up to $3.5 mill
- Tone
- Positive 75/100
- Event
- Balance sheet
- Published
- 14 Jun 2026 11:15
- Source
- Insider Monkey
Cerus Corporation Closes New Debt Facility of Up to $110 Million
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 08 Jun 2026 12:30
- Source
- Business Wire
Should I buy Cerus (CERS)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Zacks Investment Research
Significant Cerus shareholder to oppose CEO and pay chair at June 2 vote
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- Stock Titan
Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG
- Tone
- Positive 84/100
- Event
- Analyst action
- Published
- 23 May 2026 07:00
- Source
- Market source
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis (NASDAQ:CERS)
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 10 May 2026 07:00
- Source
- Seeking Alpha
Cerus Corporation Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 May 2026 12:30
- Source
- Moby
Cerus Corp (CERS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 01 May 2026 07:17
- Source
- GuruFocus.com
Cerus (CERS) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- The Motley Fool
Cerus wins 4-year deal with French blood network serving 330,000 units
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 27 Apr 2026 07:00
- Source
- Stock Titan
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Market source
Cerus (CERS) Revenue Growth Outpaces Market And Reinforces Bullish Margin Recovery Narrative
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 04 Mar 2026 08:00
- Source
- simplywall.st
Cerus Corporation (CERS) Stock Rises on Q4 2025 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Mar 2026 08:00
- Source
- Quiver Quantitative
Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Mar 2026 08:00
- Source
- Market source
Cerus Corporation (NASDAQ:CERS) Held Back By Insufficient Growth Even After Shares Climb 27%
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Jan 2026 08:00
- Source
- simplywall.st
Cerus (CERS) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2025 00:32
- Source
- Stock Titan
Cerus Markets Review 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2024 07:00
- Source
- Investing.com
Cerus (CERS) Stock Price, News & Analysis $CERS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Aug 2016 18:25
- Source
- MarketBeat